GLP-1 Compounded Drug Prices Have Been Compiled
A new index tracks the cost of compounded semaglutide and tirzepatide across 21 U.S. telehealth programs.
Updated on Oct. 12, 2026 in Weight Loss
Live Poll
Do you trust that online telehealth programs clearly disclose the full monthly cost of your medication?
The October 2026 GLP-1 Price Index, released by NexLife, provides a comprehensive overview of monthly costs for compounded versions of popular weight-loss medications. This report is designed to help consumers navigate the varying pricing models offered by online health providers.
Why it matters
Understanding the pricing landscape for compounded GLP-1 medications is crucial for patients weighing treatment options, as these costs can vary significantly between different telehealth platforms. The index provides a rare, transparent look at what patients might pay for these non-FDA-approved drugs.
The index aggregates pricing from 21 U.S. telehealth programs, utilizing all-in, month-to-month pricing that incorporates required membership fees. Findings show median prices of $222 for compounded tirzepatide and $175 for compounded semaglutide, though quality and safety remain unverified.
The players
NexLife
A Wilmington, Delaware-based company that provides health-focused research and tracking.
The details
The report highlights that a majority of surveyed telehealth programs apply flat monthly pricing that does not change regardless of the patient's specific dose. These all-in costs incorporate both the medication and the necessary membership fees required to access the provider platform. It is important to note that unlike the brand-name versions, compounded medications are not FDA-approved, meaning they have not undergone the same rigorous federal oversight for safety and efficacy.
Timeline
• Price data collection occurred between October 7 and October 8, 2026.
• The October 2026 index was officially released on October 12, 2026.
Health Landscape
This index emerges as patients increasingly turn to compounded alternatives for GLP-1 therapy amid high demand for brand-name drugs. These products operate outside the standard FDA drug approval process, necessitating a cautious approach from consumers regarding safety and consistency.
If you are considering compounded GLP-1 medications, prioritize discussions with your primary physician about the lack of FDA approval and potential safety implications. Compare the total monthly costs, including membership fees, to ensure you have a full picture of your out-of-pocket expenses.
The takeaway
While price transparency is helpful for financial planning, the most critical factor remains the safety and oversight of the medications you take. Always verify with your doctor whether a specific compounded treatment is appropriate and safe for your unique health needs.
Further reading
Learn more about the latest developments in weight management by visiting our Weight Loss section.
More information
Review the detailed figures and program breakdown in the complete GLP-1 price index.
Live Poll
Do you trust that online telehealth programs clearly disclose the full monthly cost of your medication?
